Drug Profile
Adefovir
Alternative Names: GS 0393; GS 393; Phosphonylmethoxyethyl-a; PMEALatest Information Update: 23 Sep 2021
Price :
$50
*
At a glance
- Originator Academy of Sciences of the Czech Republic; Nonindustrial source; Rega Institute for Medical Research
- Developer Academy of Sciences of the Czech Republic; Gilead Sciences; Nonindustrial source
- Class Adenine nucleotides; Antiretrovirals; Phosphonic acids; Purine nucleotides; Small molecules
- Mechanism of Action Cell differentiation stimulants; DNA-directed DNA polymerase inhibitors; Immunomodulators; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Graft-versus-host disease; Hepatitis B; HIV infections; Rheumatic disorders
Most Recent Events
- 08 May 2000 Discontinued-II for HIV infections treatment in USA (IV)
- 08 May 2000 Discontinued-Preclinical for Hepatitis B in USA (Unknown route)
- 22 Oct 1997 Preclinical development for Cancer in Belgium (Unknown route)